Cristina B. Sanger

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

M. Burkard, J. Kratz, I. Ong, 2021, bioRxiv.

Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia

R. Striker, G. Leverson, Aos S Karim, 2023, Annals of Surgical Oncology.

Do immune inflammatory markers correlate with anal dysplasia and anal cancer risk in patients living with HIV?

R. Striker, E. Carchman, Qiuyu Yang, 2022, International Journal of Colorectal Disease.

ASO Author Reflections: Using Objective Markers to Tailor Frequency of Anal Dysplasia Treatments in People Living with HIV.

R. Striker, Cristina B. Sanger, 2023, Annals of Surgical Oncology.

Prevalence of High-Grade Anal Dysplasia and Anal Cancer in Veterans Living With HIV and CD4/CD8 Ratio as a Marker For Increased Risk

C. Voils, E. Lawson, R. Striker, 2021, Diseases of the colon and rectum.

Treating acute diverticulitis in pre‐ and post‐solid‐organ transplant patients: a single‐institution cohort study

E. Carchman, G. Leverson, C. Klos, 2023, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Analysis of >15 000 Solid Organ Transplant Recipients Reveals Nonanal Genitourinary HPV-related Disease as Highest Risk Predictor for Anal Squamous Intraepithelial Lesions/Anal Cancer.

Cristina B. Sanger, Linda Cherney-Stafford, D. Al‐Adra, 2024, Transplantation.